The Spanish Royal couple, their Majesties the King Felipe VI and the Queen Letizia, visited Japan as state guests from 4th to 7th of April and welcomed by their Majesties the Emperor and Empress of Japan. The Spanish Royal couple also met the Prime Minister Mr. Shinzo Abe and other authorities with the objective to strengthen the cultural, economic, and scientific/technological bonds between Spain and Japan.
Associate Professor Jose M. M. Caaveiro affiliated to the Graduate School of Pharmaceutical Sciences was selected by the Spanish Embassy together with other outstanding Spanish scientists working in Japan to meet the Spanish Royal couple for 45 minutes during their visit to The National Museum of Emerging Science and Innovation (Miraikan) on April 5. Spanish Foreign Affairs Minister Mr. Alfonso Dastis and Dr. Carmen Vela, the Secretary of State of Investigation, Development and Innovation (top scientific position in the Spanish government) also joined the conversation between the Spanish Royal Couple and the scientists. The group of scientists explained their research and life experience in Japan with great passion, and expressed their interest in increasing the scientific and cultural exchanges with partner Spanish universities and research centers. The King Felipe VI thanked the group of scientists for their brilliant work, and for their effort to illustrate the positive values of Spain and the Spanish culture to fellow Japanese colleagues.
Associate Professor Jose M. M. Caaveiro was born in the northern region of Spain, obtaining his PhD. from the University of the Basque Country. After a few years in America at the Massachusetts Institute of Technology and at Brandeis University as a postdoctoral researcher, Dr. Caaveiro moved to Japan in 2007. Soon after, he incorporated to The University of Tokyo where he was promoted to a senior research position. On February 2017 he joined the faculty of Kyushu University as an Associated Professor, bringing an exciting research and educational program aimed at critical issues of human health such as chronic pain, cancer, Parkinson’s disease, or AIDS, in the newly established laboratory of Global Healthcare in the Graduate School of Pharmaceutical Sciences.